CiiTA Managing Partner Jason Hardaway to Speak at 340B Manufacturer Summit

PORTLAND, Ore. – May 9, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming 340B Manufacturer Summit in Washington, DC August 18-19, 2016. This event, hosted by CBI, breaks down and clarifies the impending regulations impacting 340B programs, provides strategies to develop comprehensive self-disclosure response and auditing processes, and best practices to collaborate with contract pharmacies and covered entities.

Mr. Hardaway’s presentation at the CBI conference will be on Friday, August 19, 2016 within the 340B 101 Bootcamp workshop, and he will address the pros and cons of auditing covered entities and and will provide insight into what manufacturers can expect of a HRSA audit.

For more information on the August 18-19 CBI conference, click here. (https://www.cbinet.com/conference/pc16378)

Jason Hardaway is a recognized expert on the federal 340B Program and a frequent presenter or panel member at 340B industry events.

CiiTA, LLC provides unique expertise and actionable market intelligence to pharmaceutical and biotechnology manufacturers participating in the 340B Drug Discount Program. We apply in-depth knowledge of 340B Program regulations and custom research to help manufacturers maintain strict compliance with Program guidelines while mitigating the financial risk of Program abuse.